Silver Book Fact

The projected economic value of eliminating deaths from stroke is $7.6 trillion.

Murphy K, Topel R. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003. https://press.uchicago.edu/ucp/books/book/chicago/M/bo3643529.html

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy K, Topel R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset
    A study of the effectiveness of treating ischemic stroke victims with rt-PA within 3 hours of symptom onset found an estimated impact on long-term health outcomes of 564 quality-adjusted life-years saved…  
  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • While treatment with antihypertensives has already generated a benefit-to-cost ratio of at least 6:1 (6:1 for women and 10:1 for men), more effective use of antihypertensive medication would have an…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.